Format

Send to

Choose Destination
Int J Psychiatry Clin Pract. 2017 Nov;21(4):259-265. doi: 10.1080/13651501.2017.1315138. Epub 2017 Apr 24.

Flibanserin - the female Viagra?

Author information

1
a Department of Psychiatry , University of California San Diego , San Diego , CA , USA.
2
b Arbor Scientia , Carlsbad , CA , USA.
3
c Department of Psychiatry , University of Cambridge , Cambridge , UK.

Abstract

This article provides a clinically relevant review of the first medication approved by the US Food and Drug Administration for hypoactive sexual desire disorder (HSDD) in premenopausal women. In this short piece, the human sexual response cycle and its relevance to HSDD will be described as well as the pharmacological mechanism of action of flibanserin. Finally, efficacy and safety data of this new medication will be summarised.

KEYWORDS:

Flibanserin; hypoactive sexual desire disorder; premenopausal women

PMID:
28434386
DOI:
10.1080/13651501.2017.1315138
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center